SCHEMBL4845406

SCHEMBL4845406

CC[N+]1(CC)CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL575072 1.00 CHRNA7 (0.39)
Hydrochloric Acid SCHEMBL9098929 0.96
SCHEMBL575245 0.86 CHRNA7 (0.33)
SCHEMBL575435 0.84
SCHEMBL9864651 0.84
SCHEMBL17550748 0.84 CHRNA7 (0.36)
SCHEMBL575736 0.83 CHRNA7 (0.37)
Hydrochloric Acid SCHEMBL15366520 0.81 CHRNA7 (0.34)
Water SCHEMBL16297127 0.81 CHRNA7 (0.34)
SCHEMBL2865219 0.81 CHRNA7 (0.34)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2934594-B1 CYCLOHEXYL AND QUINUCLIDINYL CARBAMATE DERIVATIVES HAVING BETA2 ADRENERGIC AGONIST AND M3 MUSCARINIC ANTAGONIST ACTIVITIES . ALMIRALL SA (ES) 2019-09-04 EP disclosed
CN-105142673-B Novel cyclohexyl and quininuclidinyl carbamate derivatives with beta 2-adrenergic activator and M3 muscarinic antagonists activity 阿尔米雷尔有限公司 2018-01-05 CN disclosed
US-9518050-B2 Cyclohexyl and quinuclidinyl carbamate derivatives having β2 adrenergic agonist and M3 muscarinic antagonist activity ALMIRALL, S.A. (ES) 2016-12-13 US disclosed
CN-105142673-A New cyclohexyl and quinuclidinyl carbamate derivatives having beta2 adrenergic agonist and M3 muscarinic antagonist activity ALMIRALL SA 2015-12-09 CN disclosed
US-20150329535-A1 NEW CYCLOHEXYL AND QUINUCLIDINYL CARBAMATE DERIVATIVES HAVING BETA2 ADRENERGIC AGONIST AND M3 MUSCARINIC ANTAGONIST ACTIVITY ALMIRALL, S.A. (ES) 2015-11-19 US disclosed
EP-2934594-A1 NEW CYCLOHEXYL AND QUINUCLIDINYL CARBAMATE DERIVATIVES HAVING BETA2 ADRENERGIC AGONIST AND M3 MUSCARINIC ANTAGONIST ACTIVITY Almirall, S.A. (ES) 2015-10-28 EP disclosed
WO-2014095920-A1 NEW CYCLOHEXYL AND QUINUCLIDINYL CARBAMATE DERIVATIVES HAVING BETA2 ADRENERGIC AGONIST AND M3 MUSCARINIC ANTAGONIST ACTIVITY ALMIRALL, S.A. (ES) 2014-06-26 WO disclosed
US-7318477-B2 Method and composition for cleaning a well bore prior to cementing AKZO NOBEL N.V. (NL) 2008-01-15 US disclosed
US-7238801-B2 Phthalocyanine compound, method for production thereof, and near infrared absorbing dye and near infrared absorbing filter using same NIPPON SHOKUBAI CO., LTD. (JP) 2007-07-03 US disclosed
US-20060254770-A1 Method and composition for cleaning a well bore prior to cementing NOURYON CHEMICALS INTERNATIONAL B.V. (NL) 2006-11-16 US disclosed
US-20030234995-A1 Phthalocyanine compound, method for production thereof, and near infrared absorbing dye and near infrared absorbing filter using same NIPPON SHOKUBAI CO., LTD. (JP) 2003-12-25 US disclosed
US-6196320-B1 Method of cleaning a well bore prior to installing a water based fluid system DEEP SOUTH CHEMICAL, INC. 2001-03-06 US disclosed
WO-2000057023-A1 METHOD OF CLEANING A WELL BORE PRIOR TO INSTALLING A WATER BASED FLUID SYSTEM DEEP SOUTH CHEMICAL, INC. (US) 2000-09-28 WO disclosed
WO-1999037884-A1 METHOD OF CLEANING A WELL BORE PRIOR TO CEMENTING DEEP SOUTH CHEMICAL, INC. (US) 1999-07-29 WO disclosed
US-5904208-A Method of cleaning a well bore prior to cementing DEEP SOUTH CHEMICAL (US) 1999-05-18 US disclosed
WO-1999002577-A1 MODIFIED PHENOL-FORMALDEHYDE RESIN AND PROCESS OF MAKING THE SAME PERSTORP AB (SE) 1999-01-21 WO disclosed
US-5026897-A Chemically mask cholinesterase enzymes; antispasmotic agents THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE ARMY (US) 1991-06-25 US disclosed
US-4973734-A ANTIDIOTE FOR ORGANOPPHOSPHATE POISONING THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE ARMY (US) 1990-11-27 US disclosed
EP-0220988-B1 PROCESS FOR CULTURING BABESIA CANIS, USE IN THE PREPARATION OF ANTIGENS AND VACCINES, AND ANTIGENS AND VACCINES AGAINST PIROPLASMOSIS RHONE MERIEUX (FR) 1990-05-30 EP disclosed
EP-0220988-A1 Process for culturing Babesia canis, use in the preparation of antigens and vaccines, and antigens and vaccines against piroplasmosis RHONE MERIEUX (FR) 1987-05-06 EP disclosed